From long-standing health burdens to emerging viral threats, infectious diseases continue to test public health systems around the world. This eBook brings together expert insights and new research to unpack the complex, fast-moving world of pathogen science, prevention efforts, and the technologies reshaping how we respond.
Download the eBook
Here’s a look at what’s inside:
- Herpes and Hidden Burdens: A closer look at the growing global impact of herpes infections—and what new data is telling us about their true burden.
- Lesser-Known Viruses, Big Implications: Why diseases like the Oropouche virus are raising red flags for surveillance and early warning systems.
- AI and the Next Pandemic: Can artificial intelligence help predict future outbreaks? Explore the tools changing how we prepare for what’s next.
- When the Microbiome Goes Off Balance: Understanding Candida overgrowth and how internal microbial shifts affect our vulnerability to infection.
- Progress and Pitfalls in Hepatitis Elimination: A global update on what’s working, what’s not, and what’s next in the fight against hepatitis.
- Animal-Human Crossovers: The recent spread of H5N1 bird flu to horses is sparking new conversations about viral evolution and spillover risk.
This edition highlights how human and animal health are deeply connected, why early detection matters more than ever, and how science and technology are helping shape a smarter global response.
Download the full eBook to explore what’s next in infectious disease research and response.
Download the eBook
About Illumina, Inc.
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina's innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.